Advertisement

Supply Chain



Inventory costs and warehousing prices reached record high levels in March, according to the Logistics Managers' Index Report published April 5. 

The U.S. is further restricting access to GlaxoSmithKline's COVID-19 antibody drug sotrovimab in response to research suggesting it is ineffective against the omicron subvariant BA.2, now the country's dominant strain.

National and global factors like the Russia-Ukraine war are complicating supply chain issues in the U.S., with health systems expecting to see price hikes in certain medical supplies for which raw materials are sourced in Russia. 

Advertisement

Most Read

Advertisement
Advertisement